NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

You might also be interested in reading Roche to close $1.5B acquisition of Poseida Therapeutics.